Halozyme Therapeutics, Inc. (FRA:RV7)
Germany
· Delayed Price · Currency is EUR 55.20
-1.00 (-1.78%)
At close: Dec 4, 2025
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of €6.40 billion as of December 5, 2025. Its market cap has increased by 18.90% in one year.
Market Cap
6.40B
Enterprise Value
7.12B
Revenue
1.06B
Ranking
n/a
PE Ratio
12.61
Stock Price
€55.20
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 6.40B, an increase of 4,419.29%. That is a compound annual growth rate of 19.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.47B |
| Deutsche Telekom AG | 130.38B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.66B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |